Japan Clears First iPSC Therapies for Clinical Use
March 25, 2026
Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials
2 min read
False
Advertisement
Industry News
Hoth Applies AI in Development of Candidate for KIT-Driven Cancers
By Julia Cipriano
March 19, 2026
Preclinical results and AI integration support progress toward regulatory submission
1 min read
Manufacturing Inside the Patient
By Priya Baraniak
March 17, 2026
How 2025 marked biology’s shift toward engineering discipline
3 min read
Study Explores Liver Outcomes After HIV Treatment Switch
March 5, 2026
PASO DOBLE sub-analysis reports steatosis differences at 96 weeks
1 min read
HEK293 Cell Line for rAAV Manufacturing
March 4, 2026
New study reports two-fold improvement in full-to-empty rAAV ratio versus commercial HEK293 line
2 min read
MHRA Approval for First UK-made mRNA Vaccine
February 27, 2026
Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1
1 min read
Syngene and Johns Hopkins Partner to Advance Early-Stage Drug Discovery
February 25, 2026
Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
1 min read
Cirena Launches High-Purity Long RNA to Accelerate CRISPR and Genome-Editing Research
February 23, 2026
New technology enables faster design cycles and improved editing precision
1 min read
Cell and Gene Therapy Catapult Establishes Technology Advisory Board
February 19, 2026
New board will identify opportunities for the advanced therapies sector to deploy and benefit from innovations
2 min read
GSK’s RSV Vaccine Moves Closer to China Approval
February 18, 2026
Regulatory filing for Arexvy has been accepted for review in China for adults aged 60 and older, where RSV affects millions each year
2 min read
